IMMUCELL CORP /DE/ - COM PAR (ICCC)

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / COM PAR
Number of holders
17
Total 13F shares, excl. options
756,437
Shares change
-11,650
Total reported value, excl. options
$5,309,000
Value change
-$102,080
Number of buys
4
Number of sells
-7
Price
$7.04

Significant Holders of IMMUCELL CORP /DE/ - COM PAR (ICCC) as of Q4 2018

19 filings reported holding ICCC - IMMUCELL CORP /DE/ - COM PAR as of Q4 2018.
IMMUCELL CORP /DE/ - COM PAR (ICCC) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 756,437 shares .
Largest 10 shareholders include HEARTLAND ADVISORS INC (199,600 shares), PERRITT CAPITAL MANAGEMENT INC (154,300 shares), RENAISSANCE TECHNOLOGIES LLC (91,806 shares), INGALLS & SNYDER LLC (91,511 shares), Vanguard Group Inc (77,813 shares), SHUFRO ROSE & CO LLC (50,670 shares), Essex Financial Services, Inc. (21,000 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (16,457 shares), Minerva Advisors LLC (14,559 shares), and RBF Capital, LLC (13,086 shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.